Researchers in Japan have shown that mouse dendritic cells (DCs), which can promote or inhibit inflammation depending on the proteins displayed on their surface, include a subpopulation that exerts beneficial effects during a treatment for leukemia and other malignancies.
The treatment—known as allogeneic hematopoietic stem cell transplantation (alloHSCT)—can, in some situations, result in graft-versus-host-disease (GVHD). Acute and chronic GVHD occur when donor immune cells called T lymphocytes recognize and become activated by proteins present on recipient but not donor tissues. The resulting T lymphocyte-driven immune response can result in severe damage to the recipient skin, gastrointestinal tract and liver.
Previous work by these researchers described the generation of regulatory DCs from mouse bone marrow (BM-DCregs) that, when injected after alloHSCT, reduce the severity and incidence of acute and chronic GVHD. The team, led by Katsuaki Sato at the RIKEN Research Center for Allergy and Immunology in Yokohama, has now shown that naturally occurring counterparts of BM-DCregs exist and influence the outcome of alloHSCT in mice1.
The researchers started by searching for genes associated with immunosuppressive DC function. A comparison of the genes expressed in BM-DCregs and non-regulatory DCs revealed that the gene encoding the surface protein CD200R3 is expressed exclusively in BM-DCregs. They found that blockade of CD200R3 impaired the ability of BM-DCregs to suppress proliferation of T lymphocytes, whereas forced expression of CD200R3 in non-regulatory DCs reduced their ability to promote T lymphocyte cell division. This indicates that CD200R3 contributes to the immunosuppressive function of BM-DCregs.
Reasoning that naturally occurring regulatory DCs might also express CD200R3, the researchers screened blood and spleen cells for CD200R3 expression. They identified a small population of CD200R3-expressing cells that, like BM-DCregs, produced immunosuppressive cytokines, which are regulators of the immune system, and inhibit T cell proliferation. These CD200R3+ DCs exhibited a different morphology than non-regulatory DCs (Fig. 1).
When injected after alloHSCT, Sato and colleagues found that these CD200R3+ DCs—like BM-DCregs—suppressed the onset and severity of GVHD. Recipients of BM-DCregs contained lower amounts of serum proinflammatory proteins, and higher numbers of immunosuppressive regulatory T lymphocytes. Further highlighting the biological importance of BM-DCregs, pre-treatment with a CD200R3-blocking antibody prior to alloHSCT exacerbated GVHD.
“The functional identification of naturally occurring human DCregs, as well as their counterparts generated the laboratory, may provide an advantageous means of intervening to prevent chronic GVHD after alloHSCT” says Sato.
1. Sato, K., Eizumi, K., Fukaya, T., Fujita, S., Sato, Y., Takagi, H., Yamamoto, M., Yamashita, N., Hijikata, A., Kitamura, H., Ohara, O., Yamasaki, S., Saito, T. & Sato, K. Naturally occurring regulatory dendritic cells regulate murine cutaneous chronic graft-versus-host disease. Blood 113, 4780–4789 (2009).
The corresponding author for this highlight is based at the RIKEN Laboratory for Dendritic Cell Immunobiology
Saeko Okada | Research asia research news
Further reports about: > BM-DCregs > CD200R3 > RIKEN > T lymphocyte > T lymphocyte cell division > T lymphocyte-driven immune response > chronic GVHD > dendritic cells > different morphology > graft-versus-host-disease > immune cell > immunosuppressive cytokines > inflammation > mouse bone marrow > mouse dendritic cells
Novel mechanisms of action discovered for the skin cancer medication Imiquimod
21.10.2016 | Technische Universität München
Second research flight into zero gravity
21.10.2016 | Universität Zürich
Researchers from the Institute for Quantum Computing (IQC) at the University of Waterloo led the development of a new extensible wiring technique capable of controlling superconducting quantum bits, representing a significant step towards to the realization of a scalable quantum computer.
"The quantum socket is a wiring method that uses three-dimensional wires based on spring-loaded pins to address individual qubits," said Jeremy Béjanin, a PhD...
In a paper in Scientific Reports, a research team at Worcester Polytechnic Institute describes a novel light-activated phenomenon that could become the basis for applications as diverse as microscopic robotic grippers and more efficient solar cells.
A research team at Worcester Polytechnic Institute (WPI) has developed a revolutionary, light-activated semiconductor nanocomposite material that can be used...
By forcefully embedding two silicon atoms in a diamond matrix, Sandia researchers have demonstrated for the first time on a single chip all the components needed to create a quantum bridge to link quantum computers together.
"People have already built small quantum computers," says Sandia researcher Ryan Camacho. "Maybe the first useful one won't be a single giant quantum computer...
COMPAMED has become the leading international marketplace for suppliers of medical manufacturing. The trade fair, which takes place every November and is co-located to MEDICA in Dusseldorf, has been steadily growing over the past years and shows that medical technology remains a rapidly growing market.
In 2016, the joint pavilion by the IVAM Microtechnology Network, the Product Market “High-tech for Medical Devices”, will be located in Hall 8a again and will...
'Ferroelectric' materials can switch between different states of electrical polarization in response to an external electric field. This flexibility means they show promise for many applications, for example in electronic devices and computer memory. Current ferroelectric materials are highly valued for their thermal and chemical stability and rapid electro-mechanical responses, but creating a material that is scalable down to the tiny sizes needed for technologies like silicon-based semiconductors (Si-based CMOS) has proven challenging.
Now, Hiroshi Funakubo and co-workers at the Tokyo Institute of Technology, in collaboration with researchers across Japan, have conducted experiments to...
14.10.2016 | Event News
14.10.2016 | Event News
12.10.2016 | Event News
21.10.2016 | Health and Medicine
21.10.2016 | Information Technology
21.10.2016 | Materials Sciences